Integral Diagnostics Stock Price To Earnings To Growth
| IDX Stock | 2.15 0.02 0.94% |
Integral Diagnostics fundamentals help investors to digest information that contributes to Integral Diagnostics' financial success or failures. It also enables traders to predict the movement of Integral Stock. The fundamental analysis module provides a way to measure Integral Diagnostics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Integral Diagnostics stock.
Integral | Price To Earnings To Growth |
Integral Diagnostics Company Price To Earnings To Growth Analysis
Integral Diagnostics' PEG Ratio indicates the potential value of an equity instrument and is calculated by dividing Price to Earnings (P/E) ratio into earnings growth rate. Most analysts and investors prefer this measure to a Price to Earnings (P/E) ratio because it incorporates the future growth of a firm. The low PEG ratio usually implies that an equity instrument is undervalued; whereas PEG of 1 may indicate that an equity is reasonably priced under given expectations of future growth.
Generally speaking, PEG ratio is a 'quick and dirty' way to measure how the current price of a firm's stock relates to its earnings and growth rate. The main benefit of using PEG ratio is that investors can compare the relative valuations of companies within different industries without analyzing their P/E ratios.
| Competition |
Based on the latest financial disclosure, Integral Diagnostics has a Price To Earnings To Growth of 0.0 times. This indicator is about the same for the Health Care Providers & Services average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all Australia stocks average (which is currently at 0.0).
Did you try this?
Run Funds Screener Now
Funds ScreenerFind actively-traded funds from around the world traded on over 30 global exchanges |
| All Next | Launch Module |
Integral Fundamentals
| Return On Equity | 0.0114 | ||||
| Return On Asset | 0.0257 | ||||
| Profit Margin | 0.01 % | ||||
| Operating Margin | 0.08 % | ||||
| Current Valuation | 1.29 B | ||||
| Shares Outstanding | 371.6 M | ||||
| Shares Owned By Insiders | 9.42 % | ||||
| Shares Owned By Institutions | 23.79 % | ||||
| Price To Book | 1.14 X | ||||
| Price To Sales | 1.63 X | ||||
| Revenue | 469.7 M | ||||
| Gross Profit | 155.53 M | ||||
| EBITDA | 12.33 M | ||||
| Net Income | (60.7 M) | ||||
| Total Debt | 357.8 M | ||||
| Book Value Per Share | 1.86 X | ||||
| Cash Flow From Operations | 66.16 M | ||||
| Earnings Per Share | 0.02 X | ||||
| Target Price | 3.15 | ||||
| Number Of Employees | 1.98 K | ||||
| Beta | 0.7 | ||||
| Market Capitalization | 798.95 M | ||||
| Total Asset | 744.28 M | ||||
| Retained Earnings | (24.96 M) | ||||
| Working Capital | (10.86 M) | ||||
| Annual Yield | 0.03 % | ||||
| Net Asset | 744.28 M | ||||
| Last Dividend Paid | 0.058 |
About Integral Diagnostics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Integral Diagnostics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Integral Diagnostics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Integral Diagnostics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Integral Stock Analysis
When running Integral Diagnostics' price analysis, check to measure Integral Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Integral Diagnostics is operating at the current time. Most of Integral Diagnostics' value examination focuses on studying past and present price action to predict the probability of Integral Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Integral Diagnostics' price. Additionally, you may evaluate how the addition of Integral Diagnostics to your portfolios can decrease your overall portfolio volatility.